The recent instability in global chains have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes nations to significant vulnerabilities, including delivery delays, price fluctuations, and even geopolitical threats. Shifting towards domestic production of Ivermectin offers a multit